Search results for " ALZHEIMER"

showing 10 items of 149 documents

The Effect of Adherence to the Mediterranean Diet on Late-Life Cognitive Disorders: A Systematic Review

2020

Objectives: Although some results are conflicting, numerous investigations have demonstrated that the Mediterranean Diet (MedDiet) has positive effects on brain health. This review intends to provide an update on the scientific evidence regarding the effects of adherence to the MedDiet on late-life cognitive disorders. Design: A systematic review was performed. The PubMed and Scopus databases were searched for longitudinal studies and randomized controlled trials (RCTs) published between the databases’ inceptions and May 4, 2020. PRISMA guidelines were followed; the quality of the studies was assessed using version 2 of the Cochrane risk-of-bias tool for the RCTs and the Newcastle-Ottawa Sc…

GerontologyMediterranean dietDiseaseMediterraneanDiet Mediterraneanlaw.invention03 medical and health sciences0302 clinical medicineCognitionRandomized controlled trialsystematic reviewlawAlzheimer DiseaseMediterranean dietmedicineDementiaHumansCognitive Dysfunction030212 general & internal medicineEffects of sleep deprivation on cognitive performanceCognitive declineGeneral NursingAgedModalitiesbusiness.industryHealth PolicyCognitionGeneral MedicineAlzheimer's diseaseMiddle Agedmedicine.diseaseMCIDietcognitive decline and performanceAlzheimer's disease; MCI; Mediterranean diet; cognitive decline and performance; dementia; systematic review; Aged; Cognition; Humans; Middle Aged; Alzheimer Disease; Cognition Disorders; Cognitive Dysfunction; Diet MediterraneanGeriatrics and Gerontologysystematic review.businessCognition Disorders030217 neurology & neurosurgerydementia
researchProduct

Dietary Approaches and Supplements in the Prevention of Cognitive Decline and Alzheimer';s Disease

2016

Age-associated cognitive decline and dementia are conditions in which there is deterioration in memory, thinking, and behavior, with profound effects on the ability to perform everyday activities and well-being. Even if dementia mainly affects older persons, it is not a normal part of aging. Alzheimer's disease accounts for 60-75% of dementia cases. The number of persons affected will increase in the next decades in parallel with aging of the world population. Hence, unless some approach is found to reduce age-related deterioration of cognitive functions, health care costs will continue to rise exponentially. There is a wealth of epidemiological evidence supporting a relationship between di…

Gerontologymedicine.medical_specialtyDiet therapyDiseasePrevention of dementia03 medical and health sciences0302 clinical medicineAlzheimer DiseaseFatty Acids Omega-3Drug DiscoveryEpidemiologymedicineHumansNutrition Cognitive decline Alzheimer Aging Diet Oxidative stress Inflammation Supplement.Dementia030212 general & internal medicineCognitive declinePharmacologybusiness.industryCognitionVitaminsmedicine.diseaseTreatment OutcomeDietary SupplementsPlant PreparationsAlzheimer's diseaseCognition Disordersbusiness030217 neurology & neurosurgeryDiet TherapyCurrent Pharmaceutical Design
researchProduct

ETHICS AND AGING: FOCUS ON LIVING WILL FOR PATIENTS WITH DEMENTIA

2017

Today dementia certainly represents a public health priority with a huge global impact on wordwide population. However, clinical and social issues related to dementia have long been marginalized. The actual high prevalence of dementias requires also to face issues from a bioethical perspective, regarding how to deal with demented patient’s disposition. There are currently no specific guidelines on the national territory regarding whether to draw up a living will by a patient with dementia, neither about the informative role of physicians during the progressive story of the disease.

Gerontologymedicine.medical_specialtySettore MED/09 - Medicina InternaPopulationDiseaselcsh:GeriatricsSocial issuesLiving will dementia Alzheimer geriatricsmental disordersmedicinegeriatrics.DementiaeducationPsychiatryGeriatricseducation.field_of_studybusiness.industryPublic healthPerspective (graphical)BioethicsLiving willmedicine.diseaselcsh:RC952-954.6Alzheimerbusinessdementia
researchProduct

Efecto de la ingesta de glutamato monosódico en la fisiopatología de la Enfermedad de Alzheimer

2020

INTRODUCCIÓN: el glutamato es el principal neurotransmisor excitatorio del sistema nervioso. Su exceso produce excitotoxicidad por sobreestimulación de los receptores NMDA y aumento de calcio intracelular, derivando en muerte neuronal. Su sal sódica, el glutamato monosódico (GMS), es un potenciador de sabor muy utilizado en la comida procesada. La EA es una enfermedad neurodegenerativa y la forma más común de demencia. Se caracteriza por presencia de placas de péptido β-amiloide, ovillos neurofibrilares e hiperfosforilación de la proteína Tau. Su clínica implica pérdida de memoria y disfunción cognitiva progresiva. Además, se ha descrito una excitotoxicidad por exceso de glutamato en el med…

GlutamatoBeta AmiloideEnfermedad de AlzheimerExcitotoxicidadUNESCO::CIENCIAS MÉDICASMemoriaLTPp-Tau:CIENCIAS MÉDICAS [UNESCO]
researchProduct

Reduced graphene oxide decorated with metals nanoparticles electrode as electrochemical sensor for dopamine

2019

Dopamine (DA) is one of the most important neurotransmitters that influences the processes that involve memory, sleep, mood, learning among others [1]. In fact, in the last years, dopamine concentration in human body fluids has been related to some neurodegenerative diseases, such as Parkinson and Alzheimer's diseases [2]. The possibility to have a bio-marker for these disease is of extreme importance because, disease related with dementia, are diagnosed when they are already developed and their management become almost impossible. The possibility to continuously monitor DA level in fluids, such as blood and urine, could accelerate the early diagnosis of these diseases. The principal analyt…

GrapheneChemistryDopamine sensors Alzheimer's diseases electrochemical sensorsOxideNanoparticleNanotechnologylaw.inventionElectrochemical gas sensorchemistry.chemical_compoundSettore ING-IND/23 - Chimica Fisica ApplicatalawDopamineHigh pressureIn situ analysisSettore ING-IND/17 - Impianti Industriali MeccaniciElectrodemedicinemedicine.drug2019 IEEE International Conference on Flexible and Printable Sensors and Systems (FLEPS)
researchProduct

Role of physical activity in ameliorating neuropsychiatric symptoms in Alzheimer disease: A narrative review

2019

Objective: Neuropsychiatric symptoms (NPs) affect almost all patients with Alzheimer disease (AD). Because of the complications associated with the pharmacological treatment, nonpharmacological treatment (such as physical activity) can be considered as an additional complementary treatment option for NPs. The aim of this review is to evaluate the impact of physical activity on NPs in patients with AD. Methods: We searched Pubmed and Google Scholar for potential eligible articles until March 1, 2018. Results: Although there are contradictory results showing the impact of physical exercise on NPs, most of them reported that it had a significant effect on depression and sleep disturbances in p…

Hypothalamo-Hypophyseal SystemPituitary-Adrenal SystemPhysical exerciseDiseaseBioinformatics03 medical and health sciences0302 clinical medicineNeurotrophic factorsAlzheimer DiseasemedicineHumansApathyExerciseDepression (differential diagnoses)030214 geriatricsbusiness.industryMental DisordersAlzheimer disease neuropsychiatric symptoms physical activity physical exercisemedicine.diseaseExercise TherapyPsychiatry and Mental healthDisinhibitionA narrative review- INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY cilt.34 sa.9 ss.1316-1325 2019 [Veronese N. Solmi M. Basso C. Smith L. SOYSAL P. -Role of physical activity in ameliorating neuropsychiatric symptoms in Alzheimer disease]AnxietyGeriatrics and Gerontologymedicine.symptomAlzheimer's diseasebusiness
researchProduct

Impact of the Relationship of Stress and the Immune System in the Appearance of Alzheimer’s Disease

2016

The understanding of how the immune system works, as well as its relationship with the stress level, seems to be important at the start of the Alzheimer’s disease (AD). To analyze this, immunoglobulin A (IgA) and cortisol in saliva were measured using ELISA in patients with mild AD and healthy volunteers, and the production of both biomarkers was compared and correlated. In participants without AD, IgA was higher when cortisol was lower, and the opposite happened in participants with AD, with the quantification in saliva being a suitable method to determine it. Sin financiación 1.635 SJR (2017) Q1, 12/108 Geriatrics and Gerontology, 239/2885 Medicine (miscellaneous), 64/529 Psychiatry and M…

Immunoglobulin AMaleSalivaHydrocortisoneEnfermedad del sistema nerviosoDiseaseStatistics NonparametricStress level03 medical and health sciences0302 clinical medicineImmune systemAlzheimer DiseaseEnfermedad de AlzheimermedicineHumansIn patientSalivaHydrocortisoneAgedEstrésbiologybusiness.industryGeneral NeuroscienceEstrés mentalGeneral Medicinemedicine.disease030227 psychiatryImmunoglobulin APsychiatry and Mental healthClinical PsychologyEfectos fisiológicosImmune SystemImmunologybiology.proteinFemaleGeriatrics and GerontologyAlzheimer's diseasebusiness030217 neurology & neurosurgeryStress Psychologicalmedicine.drug
researchProduct

Immunosenescence, inflammation and Alzheimer’s disease

2012

Abstract Ageing impacts negatively on the development of the immune system and its ability to fight pathogens. Progressive changes in the T-cell and B-cell systems over the lifespan of individuals have a major impact on the capacity to respond to immune challenges. The cumulative age-associated changes in immune competence are termed immunosenescence that is characterized by changes where adaptive immunity deteriorates, while innate immunity is largely conserved or even upregulated with age. On the other hand, ageing is also characterized by “inflamm-ageing”, a term coined to explain the inflammation commonly present in many age-associated diseases. It is believed that immune inflammatory p…

ImmunosenescenceImmunosenescence; Alzheimer’s disease; Inflammation; Cytokine; Chemokine; Lymphocyte; AgeingInflammationReviewDiseaseImmune systemmedicineDementiaCytokineInflammationSettore MED/04 - Patologia GeneraleInnate immune systembusiness.industryImmunosenescencebiochemical phenomena metabolism and nutritionmedicine.diseaseAcquired immune systemAgeingAgeingChemokineImmunologybacteriaLymphocytesense organsmedicine.symptombusinessAlzheimer’s disease
researchProduct

Synthesis and characterization of a new insulin conjugated nanogel for biomedical application

2015

Insulin, a metabolic hormone involved in glucose metabolism, plays also a neuroprotective role in the central nervous system being able to revert the cytotoxic processes induced by Aβ42,a peptide involved in Alzheimer's disease. To reach the brain insulin have to across the BBB therefore an additional delivery strategy results to be necessary. For these aim we performed an insulin conjugated nanogels (NGs-In). Nanogels (NGs) have a great potential in the development of “smart” nanocarriers for (bio)molecular drugs and contrast agent for bioimaging. They are formed by physically or chemically crosslinked polymer networks, characterized by a large and flexible surface available for multivalen…

Insulin nanogel Alzheimer's DiseaseSettore CHIM/07 - Fondamenti Chimici Delle Tecnologie
researchProduct

An intraoral drug delivery device for long term therapies: application in Alzheimer’s disease

2009

IntelliDrug intraoral device Alzheimer diseaseSettore CHIM/09 - Farmaceutico Tecnologico Applicativo
researchProduct